Arriving the year before an election that could set healthcare and disability policy for decades, Anne Boyer's memoir warns us of the human costs of any system that prioritizes profit over lives.
Sada Jackson remembers her mother by talking to her mom's best friend, Angela Morehead-Mugita. Angela passes along advice to Sada that Sada's mom had once given to her.
Evidence is growing that 3D mammography provides more precise images and is better at detecting breast cancer — but the jury is still out on whether it saves lives.
Artificial intelligence is now being brought to bear on mammograms and could improve the accuracy of diagnoses. But previous computerized technology to do that didn't live up to the hype.
At a recent fashion show, models came out about their diagnoses — revealing both cancer's scarring effects on their bodies, and their defiant embrace of life.
Advocates have become an essential part of the annual San Antonio Breast Cancer Symposium, an influential medical meeting. Former oncologist Elaine Schattner explains the change and its importance.
LAS VEGAS (AP) — A southern Nevada hospital foundation says it will use $10 million from a former casino owner's family to expand a breast cancer detection and treatment program for underinsured and uninsured patients.
After her double mastectomy, writer Catherine Guthrie came to embrace her new body, without breast reconstruction. But, she has learned, women have to push the medical system to support this choice.
Black women are more likely to die from breast cancer than white women. One reason may be that they face economic and cultural barriers to taking the medications that can prevent recurrence.
A nonalcoholic brew joins the growing market to help chemo patients overcome the changes in their palates that make food unappealing. And it just might help them feel better, too.
As home genetic testing continues to boom, more people are getting their DNA tested for health reasons. The tests may signal future disease, but there are many limitations that might falsely reassure.
Are some people getting too much treatment for their cancers? The answer, from the American Society of Clinical Oncology meeting in Chicago, is an emphatic yes.
An experimental therapy seems to have eradicated cancer in a patient with metastatic breast cancer who had failed every other treatment. The goal is to reliably repeat that success in more people.
An aggressive type of breast cancer — a HER2-positive tumor — often shrinks with Herceptin treatment, but side effects can be tough. Researchers say a shorter course of the drug may be a good option.
Nearly half a million English women around age 70 did not get notified that they were due for a mammogram because of a "computer algorithm error," the health secretary says.
When many lymph nodes are removed along with a tumor, some patients develop painful and debilitating swelling — lymphedema. More doctors should recognize and help prevent the problem, surgeons say.
The goal is to customize treatments for cancer and other diseases to a patient's own biology. But something as simple as failing to take care of tissue samples en route to the lab can derail that.
The absolute risk is very low. But low-dose formulations of birth control pills and other hormone-releasing contraceptives pose about the same risk to breasts as older formulations, a big study finds.
Unnecessary treatment of breast cancer and other diseases is pervasive. Overtreatment adds enormous costs to the health care system and, at times, burdens patients with needless suffering.
There are lots of "you can beat it" messages out there for cancer patients. For some, the positive spin feels insulting. The Food and Drug Administration doesn't regulate hospital ads.
